Showing 41-50 of 328 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| A Multi-task Learning Framework for Developing Genetic Risk Score (GRS) Models of T1D for Multi-Ethnic Population | University of Washington | Shuai Huang | Cures | 01-August-2022 to 31-August-2025 | $300,081.37 |
| microRNAs as regulators of stem cell differentiation into islet cells | University of Washington | Vincenzino Cirulli | Cures | 01-August-2025 to 31-July-2027 | $600,000.00 |
| Promoting functional maturation of SC-derived beta-cells by novel Epigenetic regulators | University of Washington | Vincenzino Cirulli | Cures | 01-October-2024 to 30-September-2026 | $500,000.00 |
| Structural approaches to understand biased insulin signaling and design glucose-binding proteins for smart insulin therapeutics | University of Utah | Amber Vogel | Improving Lives | 01-March-2024 to 28-February-2027 | $228,995.00 |
| Optimization of fast-acting venom insulins as therapeutic candidates for T1D | University of Utah | Helena Safavi | Improving Lives | 01-September-2022 to 31-August-2026 | $890,372.53 |
| Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Mitigate Diabetic Ketoacidosis Risk? | University of Texas Health Science Center at San Antonio | Muhammad Abdul-Ghani | Improving Lives | 01-June-2019 to 30-September-2025 | $1,573,835.31 |
| MRI of Pancreas Perfusion in Response to Glucose | University of Texas at Austin | Jack Virostko | Cures | 01-July-2023 to 30-June-2025 | $187,620.00 |
| Dock2-mediated T cell migration as a targetable shared mechanism in autoimmunity | University of Pittsburgh | Alok Joglekar | Cures | 01-September-2025 to 31-August-2026 | $149,999.05 |
| Defining the Antigenic Landscape of Islet-Infiltrating T cells in Type 1 Diabetes | University of Pittsburgh | Alok Joglekar | Cures | 01-March-2023 to 28-February-2026 | $900,000.00 |
| Injectable Glucose-Responsive Hydrogels for Multi-Hormone Therapy | University of Notre Dame | Matthew Webber | Improving Lives | 01-March-2020 to 28-February-2026 | $750,000.00 |